Faron Pharmaceuticals Oy (LON:FARN) Stock Passes Below Fifty Day Moving Average – What’s Next?

by · The Markets Daily

Faron Pharmaceuticals Oy (LON:FARN – Get Free Report)’s stock price passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 185.68 and traded as low as GBX 183. Faron Pharmaceuticals Oy shares last traded at GBX 183, with a volume of 264 shares.

Faron Pharmaceuticals Oy Trading Up 0.3%

The firm has a 50 day moving average of GBX 185.68 and a 200 day moving average of GBX 201.11. The firm has a market cap of £208.44 million, a PE ratio of -6.78 and a beta of 0.36. The company has a quick ratio of 1.09, a current ratio of 1.45 and a debt-to-equity ratio of 922.55.

Faron Pharmaceuticals Oy Company Profile

(Get Free Report)

Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.

Featured Articles